Zheng Quan, Gao Peng, Li Xiaofeng, Li Hailiang
Second Department of General Surgery, Guangdong Second Provincial General Hospital, Guangzhou 510317, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Aug 30;39(8):891-897. doi: 10.12122/j.issn.1673-4254.2019.08.03.
To observe the inhibitory effects of PEG-APTES-MNP magnetic heating on liver cancer cells.
The magnetic nanoparticle complex PEG-APTES-MNP was synthesized and its physiochemical properties and biocompatibility were characterized. HepG2 cells were incubated with the PEG-APTES-MNP nanoparticles for magnetic heating or nanoparticle therapy. Prussian blue staining was used to detect the uptake efficiency of the magnetic nanoparticles by HepG2 cells. MTT assay and flow cytometry were used to evaluate the inhibitory effect of the nanoparticles on HepG2 cells, and laser scanning confocal microscopy was used to detect the production of reactive oxygen species (ROS) in the cells. Fifteen nude mice bearing HepG2 cell xenografts were randomized equally into PEG-APTES-MNP injection group (with nanocomposite injection only), PEG-APTES-MNP magnetic heating group and control group (with PBS injection), and the tumor growth were observed in the mice after the treatments.
The synthesized PEG-APTES-MNP nanoparticles showed good physicochemical properties and biocompatibility. Incubation of HepG2 with the nanoparticles resulted in significantly increased ROS production, obvious inhibition of the cell growth through the synergetic effects of magnetic heating ( < 0.05), and significantly enhanced cell apoptosis. In the tumor-bearing nude mice, the nanoparticles strongly inhibited the tumor growth by magnetic heating ( < 0.05).
The magnetic nanocomposite PEG-APTES-MNP has good physicochemical properties and bioavailability and can strongly inhibit the growth of liver cancer cells both and in nude mice through magnetic heating, demonstrating its potential as a candidate nanomedicine for liver cancer treatment.
观察聚乙二醇-氨丙基三乙氧基硅烷-磁性纳米颗粒(PEG-APTES-MNP)磁热效应抑制肝癌细胞的作用。
合成磁性纳米颗粒复合物PEG-APTES-MNP,并对其理化性质和生物相容性进行表征。将HepG2细胞与PEG-APTES-MNP纳米颗粒共孵育以进行磁热治疗或纳米颗粒治疗。采用普鲁士蓝染色检测HepG2细胞对磁性纳米颗粒的摄取效率。采用MTT法和流式细胞术评估纳米颗粒对HepG2细胞的抑制作用,并用激光扫描共聚焦显微镜检测细胞内活性氧(ROS)的产生。将15只荷HepG2细胞异种移植瘤的裸鼠随机均分为PEG-APTES-MNP注射组(仅注射纳米复合物)、PEG-APTES-MNP磁热组和对照组(注射PBS),观察治疗后小鼠肿瘤生长情况。
合成的PEG-APTES-MNP纳米颗粒具有良好的理化性质和生物相容性。HepG2细胞与纳米颗粒共孵育后,ROS生成显著增加,通过磁热协同效应明显抑制细胞生长(P<0.05),细胞凋亡显著增强。在荷瘤裸鼠中,纳米颗粒通过磁热效应强烈抑制肿瘤生长(P<0.05)。
磁性纳米复合物PEG-APTES-MNP具有良好的理化性质和生物利用度,可通过磁热效应在体外和裸鼠体内强烈抑制肝癌细胞生长,显示出其作为肝癌治疗候选纳米药物的潜力。